INTRODUCTION
Growth cone features that are distinctive from those of the axon shaft were noted first by Cajal (Ramó n y Cajal, 1988) . The growth cone is the motile end of the axon, is enriched in dynamic actin and microtubule (MT) components, and determines the direction of axonal growth. It has been divided into three regions: the peripheral domain containing a dense meshwork of actin forming lamellipodia and filopodia, the transition domain where actin filaments anchor into a loose MT network, and the central domain containing splayed MTs and organelles of varying size (Dent and Gertler, 2003) . Between the central domain and the axonal shaft is a region surrounded by actin where splayed MTs become bundled into dense parallel arrays (Dehmelt and Halpain, 2004 ) that we refer to as the neuronal ''wrist''. Defects in the ''wrist'' domain would therefore be predicted to result in defects in the organization of the MT cytoskeleton in the axonal shaft. The molecules that function at these transition zones have not yet been clearly defined.
Among the candidates for mediating MT bundling is Doublecortin (Dcx), a MAP with a role in MT stabilization and bundling that has been localized to the growth cone (Friocourt et al., 2003) . Dcx was initially identified as the causative gene for the human neuronal migration disorder double cortex and X-linked lissencephaly (des Portes et al., 1998) , and is expressed by postmitotic neurons. It consists of an N-terminal repeated tubulin binding domain (R1 and R2) and a C-terminal serine-proline rich domain. Deletion in mouse results in excessively branched axonal shafts in migrating neurons (Kappeler et al., 2006; Koizumi et al., 2006a) , suggesting Dcx may be required for formation of stable MT.
Recent data has highlighted the important role that Dcx phosphorylation plays in mediating MT interactions (Gdalyahu et al., 2004; Schaar et al., 2004; Tanaka et al., 2004b) . One kinase responsible for Dcx phosphorylation is cyclin-dependent kinase 5 (Cdk5), a Serine/Threonine (S/T) kinase primarily active in terminally differentiated neurons (Ohshima et al., 1996) . Cdk5 phosphorylation of Dcx at serine 297 reduces its affinity for MTs and its ability to polymerize tubulin (Tanaka et al., 2004b) . The dynamic nature of cytoskeletal reorganization underlying neurite outgrowth and migration predicts that Dcx phosphorylation, like that of other MAPs, is tightly regulated by both kinases and phosphatases. However, unlike tyrosine kinases and phosphatases that are represented in the mammalian genome in comparable numbers, the quantity of S/T kinases far exceeds that of S/T phosphatases (Ceulemans and Bollen, 2004) . Thus, phosphatase diversity only matches that of the kinases when the number of phosphatase regulators is considered. Much of the data concerning the role of S/T phosphatases for MAPs is based on results of pharmacological studies and thus potential adaptor molecules that may regulate these interactions have not been identified.
One such potential adaptor molecule with which Dcx has been shown to interact is Spinophilin (Spn), an actin binding protein with an established role in subcellular targeting of Protein phosphatase 1 (PP1), an S/T phosphatase that controls many aspects of cellular physiology (Allen et al., 1997) . Spn is able to bind and bundle F-actin, which is theorized to be important for regulating spine morphology (Satoh et al., 1998) . Consistent with these observations, Spn À/À mice exhibit abnormal spine number and formation (Feng et al., 2000) . Here, we tested the hypothesis that Spn may function as an adaptor molecule for PP1 to regulate the MAP activity of Dcx.
RESULTS

Impaired Axon Outgrowth in Dcx Mutant Brains
Corpus callosal hypoplasia is apparent in the MRIs of human males with DCX mutations ( Figure 1A ). Additionally, published data indicates that Dcx expression is upregulated in corpus callosal (CC) projection neurons during periods of axonal growth in mice (Arlotta et al., 2005) , together suggesting a potential role in axonal extension and/or stabilization. We therefore tested Dcx À/y mice for alterations in axonal outgrowth by DiI labeling projections when axons are extending in multiple regions of the brain. Injection into the medial subcortical zone at E14.5 labeled cortico-thalamic (CT) axons that extended to the corticostriatal (CS) boundary in wild-type (WT) mice ( Figure 1B ). In Dcx À/y mice, however, none of the labeled axons reached the CS boundary. By E15.5 these CT axons had extended into the region of the striatum and thalamus in WT mice, whereas only a fraction of these axons had reached the CT boundary in Dcx À/y mice, and even fewer had reached the striatum and thalamus (Figures 1C and 1D) . By E16.5, these defects became less apparent, while the corpus callosal axonal tract, which typically reaches the medial extent of the telencephalon by this time, showed a defect in axonal length ( Figure 1E ). This effect on outgrowth did not appear to be secondary to impaired neuronal migration, because Dcx knockout mice do not display discernable defects in the positioning of neurons (Corbo et al., 2002; Kappeler et al., 2006) . Although by the time of birth, these developmental delays had not resulted in clear morphological defects, these findings suggest a requirement for Dcx in timing of axonal outgrowth.
Dcx/Spn/PP1 Localization at the Wrist Suggests Possible Involvement in Axonal Outgrowth It had been shown that Dcx interacts with the PP1-adaptor protein Spn, a multidomain protein with N-terminal actin binding, PSD-95/Dig/ZO-1 homology (PDZ) and coiledcoil (CC) domains (Tsukada et al., 2003) , and our own work confirmed these results (Figures S1 and S2 in the Supplemental Data available with this article online). To determine if this interaction might play a role in the Dcx À/y Figure 1 . Delayed Axonal Extension in Dcx À/y Brains (A) Midline sagittal T1-weighted brain MRI from normal showed wellformed CC and a male with deletion of DCX exon 7-8 showed severe CC hypoplasia (arrows). Optic nerve (arrowhead), cerebellum (*), cortex (**).
(B) E14.5 DiI injected into medial subcortical region showed extensive fibers in subcortical white matter (arrow), cortico-striatal (CS) boundary (double arrows) and striatal-thalamus region (triple arrows). Mutant showed minimal axonal extension from the injection. (C) E15.5 DiI injection showed labeling of corticothalamic (CT) axons at CS boundary (box 1) and striatal-thalamus region (box 2), whereas mutant showed diminished labeling. (D) High-power views.
(E) E16.5 DiI injection showed diminished axon extension of the CC tract (arrowhead) in mutant. There was some catch-up extension of CT tract by this age (arrow).
axon growth phenotype, we assessed protein localization in cultured cortical neurons at 1 day in vitro (DIV). At this stage, neurites have a well-defined shaft capped by a growth cone, but axonal/dendritic differentiation has not yet occurred. Spn exhibited an unexpected highly distribution at the transition zone between the growth cone and axonal shaft, in the ''wrist'' region, while Dcx exhibited a characteristic enrichment along the neurite tip and around the cell body and the two showed overlapping distribution at the wrist ( Figure 2A ). PP1 showed ubiquitous localization in these neurons, but interaction in a complex with Dcx and Spn was confirmed by coimmunoprecipitation ( Figure S2A ). We next assessed the distribution of phospho-serine 297 Dcx (PSer297 Dcx) using a phospho-specific antibody (Tanaka et al., 2004b) to the Cdk5 substrate site. PSer297 Dcx showed low but detectable levels in the growth cone but was much reduced in the wrist and the axonal shaft ( Figure 2A ). Thus Spn was enriched at the wrist, and PSer297 Dcx is largely excluded from axonal shafts, consistent with a model in which Spn/PP1 may mediate dephosphorylation of PSer297 Dcx at the wrist. The close association of the MT-bound Dcx and the actin-bound Spn ( Figure 2B ) suggested that the Dcx-Spn interaction may serve to coordinate signaling between these cytoskeletal components at the wrist that may in turn be important in axon outgrowth.
Dcx and Spn Cooperate in Hippocampal Lamination and Corpus Callosum Formation
We next tested for a shared phenotype between the Dcx and Spn knockout mice, to determine if the two genes share similar roles in brain development. Dcx mutant mice display a delamination of the CA3 region of the hippocampus (Corbo et al., 2002 Figure 2C ), and there was complete agenesis of the corpus callosum (ACC), which was not observed in either of the single knockouts. The ACC was accompanied by Probst bundles, suggesting failed or delayed axonal extension across the midline during embryogenesis. To determine if this represented a more general disorder of axonal growth, the anatomy of all four genotypes was compared. We noted that the anterior commissure (AC), a major midline decussation tract connecting long-distance reciprocal olfactory and orbital-frontal regions, was hypoplastic in the DKO mouse, whereas it appeared normal in both the single knockout mice ( Figure 2C ). To exclude the possibility that these axonal phenotypes were the result of degeneration rather than failed formation, mice were examined at P0, when these projections have just completed decussation, and stained with the axonal marker L1CAM. We found that the CC decussation was absent even at this age in the DKO mouse ( Figure 2C Figure 2D ). This data suggests that Dcx and Spn cooperate to mediate long-distance axonal growth in the CC and AC during development. Neurons from all four genotypes were compared in a blinded fashion following visualization of the cytoskeleton. There were no notable differences in actin staining among the four genotypes in either the growth cone or axonal shaft, and MTs were usually observed in close approximation with actin, extending into the growth cone ( Figure 3A ). However, both Dcx À/À and Spn À/À neurons showed a poorly organized axonal MT cytoskeleton with failure to condense MTs into a single shaft. As a result of splayed and unevenly spaced MTs, axonal shafts were widened compared with WT. Neurons from DKO displayed an even broader leading process with apparently more severe failure of MT bundling. This data suggests that the axonal defects may result from impaired MT bundling in the absence of these genes.
Abnormal Inter-MT Distance in the Absence of Either Dcx or Spn
To further investigate the ultrastructural basis of this MT phenotype, transmission electron microscopic (TEM) analysis of 1DIV neurons was performed from each of the four genotypes. We noted in WT neurons that MTs were nearly always well organized in the axonal shaft and showed uniform orientation and a typical inter-MT spacing of 20-30 nm ( Figure 3B ). The neurons from the Dcx À/y and Spn À/À mice, however, showed a disordered MT array.
These MTs typically veered in oblique directions within the shaft and showed nonuniform spacing. The neurons from the DKO mice appeared even more severely disordered, with frequent MT crossing observed, suggesting a failure of bundling. To quantitate inter-MT distance (IMD), we collected high-resolution images, traced MTs along their entire visible length and measured nearest neighbor distance at uniform 250 nm intervals along the entire length of the visible neurite from at least 4 neurons of each genotype (for a total of over 300 IMD measurements from each genotype). In WT neurons, there were very few locations where MTs crossed paths, (indicated by an IMD < 20 nm) whereas these were not infrequently encountered in both single knockouts and the DKO (p < 0.05, Figure 3C ). TEM tomography was also performed from cultured neurons from on each of the four genotypes, which showed fragmented and poorly aligned MTs from the single and DKO neurons (Movies S1-S5). These results imply a failure to bundle MTs in the absence of Dcx and Spn.
Defective MT Bundling Is Associated with Excessively Branched Neurites Failure to condense neurite MTs often leads to defects in neuronal morphology at later stages of maturation (Szebenyi et al., 1998) . To test this, we analyzed morphology of mutant neurons after 36 hr in culture, a time when neurites have typically organized into stable thin processes. Striking defects in morphology were detected in neurons from both single knockouts, with an increase in branching complexity of the main process (MP) as well as an increase in the number branches extending from the cell body (i.e., body processes (BP, Figure 3D ). Quantification of the number of 2 and 3 branches from the main process as well as In Dcx À/y or Spn À/À neurons, MTs were instead splayed (arrowhead), and as a result, the neurite shaft width was increased.
(B) Transmission electron microscopy showed parallel MT arrays that maintained relatively consistent spacing along the shafts in cultured cortical neurons in WT littermates. This array was disrupted in both single knockouts and was more severe in the DKO. Bottom half (dashes) of each shows line tracings depicting MTs. 80003. (C) Binned inter-MT distance between nearest neighbor was significantly greater in mutants. n = 1499 total measurements, from 9 WT, 5 Dcx
, and 5 DKO neuronal shafts from two separate culture experiments. * = p < 0.05, chi-square contingency table. (D) WT neurons typically displayed a single monopolar main process (arrow) with occasional 2 branches (double arrow) after 36 hr in culture. Both Dcx À/y and Spn À/y neurons exhibited excessive 2 (double arrows) and 3 (triple arrows) branches from the primary neurite, as well as an increased number of processes extending from the cell soma (arrowhead). This was most striking in DKO.
(E) Quantification of neurite branching. Branches from the main process (MP) were termed 2 MP, and branches from 2 MP were termed 3 MP.
Neurites extending from the soma were termed body processes (BP), and branches from the BP were termed 2 BP.
(F) WT cells typically had a single MP, with average number of 2 MP per cell less than 0.5. The branching and frequency of 3 MP was increased in Dcx À/y , Spn À/À and DKO neurons. Furthermore, 2 BP were only noted in DKO neurons.
All error bars = SEM. * = p < 0.05, pairwise comparison, Student's t test.
the number of 1 and 2 body processes performed in a blinded fashion demonstrated statistical evidence of excess of such branches ( Figures 3E and 3F) . DKO neurons showed a further increase in the number of 2 BPs, which were only rarely observed in either WT or Dcx À/À or Spn
neurons. We conclude that Dcx and Spn cooperate for maintenance of neuronal morphology and suppression of excessive branching, which is likely a result of failure to organize the MT cytoskeleton at the wrist.
Spn and Dcx Interaction Is Sufficient to Crosslink Actin and MTs
We next tested the ability of purified Dcx and Spn to corecruit the actin and MT cytoskeletons in a cell-free assay. Recombinant Spn was added to actin previously polymerized with Alexa 488-labeled phalloidin, resulting in the formation of F-actin filaments (Figure 4) . Similarly, rhodamine-conjugated purified tubulin (previously stabilized with a low dose of taxol) was treated with recombinant Dcx, which led to the formation of MT aster-like structures from which MT bundles emanated. The combination of labeled actin and tubulin showed no particular affinity for one another, and neither did the addition of labeled tubulin to Spn-stabilized actin nor did the addition of labeled actin to Dcx-stabilized MTs. However, when Spn-stabilized actin and Dcx-stabilized MTs were combined, there was significant overlap of the two labeled cytoskeletal components. This effect was not merely due to clumping of the two cytoskeletons, because taxol/phalloidin stabilization of these cytoskeletons did not lead to overlap. This data suggests that the Dcx-Spn interaction is sufficient to mediate crosslinking of the actin and MT cytoskeletons in vitro.
PP1 Is Capable of Mediating Dephosphorylation of PSer297 Dcx
Previous work has established that the kinase Cdk5 is in a complex with the phosphatase PP1 and Spn (Agarwal-Mawal and Paudel, 2001), indicating that this complex is well poised to mediate dynamic phosphorylation/dephosphorylation of substrates. We therefore tested whether PP1 was capable of dephosphorylating the Cdk5-mediated phosphorylation of Dcx Ser297. Recombinant Dcx was added to recombinant Cdk5/p25, resulting in robust phosphorylation of Dcx at Ser297 based both on [ 32 P] autoradiogram and aPSer297 Dcx reactivity ( Figure 5A ). The addition of the nonspecific calf intestinal phosphatase (CIP) led to a reduction in both the autoradiogram signal and the reactivity with the aPSer297 Dcx. Increasing concentrations of recombinant PP1 were then compared with CIP for the ability to dephosphorylate this site. We noted a dose-dependent decrease in autoradiogram signal and aPSer297 Dcx reactivity following PP1 treatment. We conclude that PP1 is capable of mediating the dephosphorylation of PSer297 Dcx.
Spn Enhances PP1-Mediated Dephosphorylation of PSer297 Dcx
Because Spn targets PP1 to phosphoproteins, we next tested whether Spn was capable of enhancing the PP1-mediated dephosphorylation of PSer297 Dcx. The addition of even high concentrations of Spn in the absence of PP1 had no effect on PSer297 Dcx reactivity on Dcx that had been previously phosphorylated with the Cdk5/ p25 kinase ( Figure 5B ). Next, PP1 concentration was reduced to a level where it alone had no effect on the phosphorylation state of Ser297 Dcx ( Figure 5C ), and then increasing concentrations of Spn were added to this mixture. We noted a Spn dose-dependent dephosphorylation of PSer297 Dcx, which was observed both in autoradiogram and with the PSer297 Dcx antibody. We conclude that Spn is capable of enhancing the PP1-mediated dephosphorylation of PSer297 Dcx.
Modulation of PSer297-Specific Phosphorylation by Cdk5 and PP1
The previous data suggests that the Spn-PP1 complex is sufficient to mediate dephosphorylation of PSer297 Dcx. Therefore, to address whether it is necessary, we applied membrane-permeable roscovitine, a specific Cdk5 inhibitor (IC50 200 nM, versus >500 nM for cell cycle-related Cdks tested (Meijer et al., 1997) ) or tautomycin, a selective PP1 inhibitor (IC50 1nM versus >10 nM for PP2A and other phosphatases (MacKintosh and Klumpp, 1990) ) to cultured neurons. Subsequently, cells were lysed and analyzed by Western using a pan-Dcx antibody, a PSer297 Dcx-specific antibody and a PThr321 Dcx-specific antibody, the latter that recognizes a Jun kinase phosphorylation site (Gdalyahu et al., 2004) . As roscovitine concentration was increased, there was progressively less reactivity of the aPSer297 Dcx, without notable change in either total Dcx or PThr321 Dcx reactivity ( Figure 5D ). Application of tautomycin had the opposite effect, leading to an increase in aPSer297 Dcx reactivity, without change in either the total Dcx or PThr321 Dcx reactivity. We conclude that Cdk5 and PP1 reciprocally regulate the phosphorylation state of Ser297 Dcx.
PSer297 Dcx Is Excessively Phosphorylated in the Absence of Spn
In order to determine if Spn is necessary for dephosphorylation of PSer297 Dcx, we examined Spn
, Spn +/À and Spn +/+ littermates for aPSer297 Dcx reactivity. Whole brain lysates from E16 littermates were prepared, and CIP was added to half of each sample as a nonspecific phosphatase, and samples were then assayed for Spn, Dcx, and PSer297 Dcx reactivity via Western analysis. We found no notable differences in Dcx levels in any of the genotypes. However, there was dosage-dependent excessive phosphorylation of Ser297 Dcx in the Spn
and Spn À/À brain lysates ( Figure 5E ). Reactivity was 4-fold higher in the À/À than +/+ brains based on quantitative luminometry ( Figure 5F ). The data together suggests that Spn-PP1 is necessary and sufficient for PSer297 Dcx dephosphorylation.
PP1 Function Required for MT Bundling during Neurite Growth
The identification of PP1 as part of the Dcx-Spn complex in brain ( Figure S2 ) prompted us to test PP1's role in MT bundling during neurite outgrowth using genetic knockdown. PP1 consists of two regulatory subunits and a catalytic subunit (PP1g), that directly associates with Spn (MacMillan et al., 1999) . We utilized a previously validated PP1g siRNA and found a 6-fold reduction in protein expression in culture N2A cells ( Figure S3 ), suggesting that this siRNA mediates robust knockdown of PP1g expression. Cortical neurons from E13.5 WT mice underwent in utero electroporation with the PP1g siRNA and marker plasmid, isolated at E14.5, then at 1 DIV were fixed and stained to visualize the MT and actin cytoskeleton. We found that MTs failed to bundle in the majority of PP1g siRNA expressing cells ( Figure 6A ). This was quantitated by evaluating the percentage of cells with the phenotype of splayed MT in the primary neurite shaft. We found that approximately 85% of PP1g electroporated cells showed this phenotype compared with approximately 25% of controls (p < 0.01, Figure 6B ). We conclude that PP1 catalytic activity is required for bundling of MTs within the leading neurite.
MT Bundling Depends upon Association of the Dcx-Spn-PP Complex
Because of the shared MT bundling phenotype observed in Spn and Dcx knockout neurons, we hypothesized that the interaction between these two proteins might be critical for MT bundling in neurites. Because Spn aa L649-Q696 (part of the coiled-coil domain) constituted the consensus Dcx binding domain ( Figure S1A ), we deleted these residues from Spn (SpnDCC), and found that this construct failed to coimmunoprecipitate Dcx in cotransfected 293T cells ( Figure S1D ). Therefore, EGFP-Spn and EGFP-SpnDCC were tested for their ability to rescue the MT bundling defect in Spn À/À neurons. Neurons from E14 Spn À/À were electroporated with constructs encoding either plasmid, then at 1DIV were stained for MTs and EGFP, and scored for the bundling defect. The majority of Spn À/À neurons with WT Spn showed a normalization of the MT array. However, most neurons electroporated with the SpnDCC showed persistent MT bundling defects ( Figure 6C ). Quantification of the number of cells with either bundled or splayed MTs in the leading neurite showed rescue in 78% versus 25% with WT or mutant constructs, respectively ( Figure 6D , p < 0.01). We conclude that the association between Spn and Dcx is required for MT bundling. The EGFP-Spn4A (residues 457-460 KIKF) mutant construct was similarly tested, which was previously found to lack binding with PP1 (Tsukada et al., 2006) , to determine if it was capable of restoring MT bundling in Spn À/À neurons. Quantification showed the majority of cells electroporated with EGFP-Spn4A showed similar persistent MT bundling defects ( Figures 6C and 6D , p < 0.01). We conclude that the interaction between Spn, Dcx and PP1 is important for MT bundling in neurites.
Having demonstrated that the Spn/PP1 complex serves to dephosphorylate PSer297Dcx, we next tested whether Dcx phosphorylation mutants at the 297 site are capable of rescuing the MT cytoskeletal defect in Dcx À/y neurons.
The Dcx297A mutant is incapable of phosphorylation at this site, whereas the Dcx297D mutant mimics phosphorylation at this site. We found that WT but neither mutant showed a rescue of the splayed MT phenotype ( Figure 6E ). Quantification of the percentage of cells with either bundled or splayed MTs in the leading neurite showed rescue in 82% versus 19% and 14% with WT, 297A or 297D mutations, respectively ( Figure 6F , p < 0.01). Together, the data suggest that the interaction of Spn and Dcx as well as the dynamic regulation of the S297 phosphorylation state of Dcx is necessary for maintenance of the MT cytoskeleton during neurite outgrowth.
Spn-PP1-Mediated Dcx Dephosphorylation
Recovers MT Polymerizing Activity PSer297 Dcx phosphorylation by Cdk5 results in a 60% decrease in MT polymerization activity (Tanaka et al., 2004b) , and the data indicates that the Spn-PP1 complex is necessary and sufficient for dephosphorylation at this site. In order to test whether Spn-PP1-mediated PSer297 Dcx dephosphorylation might result in reactivation of its MAP activity, we employed the turbidimetric MT polymerization assay (Gleeson et al., 1999) . Application of recombinant Dcx to MAP-depleted brain-derived purified tubulin resulted in robust polymerization (Figure 7A) . We then added activated recombinant Cdk5/ p25 to phosphorylate Ser297 Dcx, and rezeroed the absorbance reading. There was a subsequent decrease in the turbidity over the following time period, suggesting that phosphorylation of Dcx by Cdk5 results in depolymerization of MTs that had been previously polymerized with Dcx. We then added roscovitine (to inactivate Cdk5), together with recombinant Spn-PP1, to dephosphorylate PSer297 Dcx, and rezeroed the absorbance reading a second time. An increase in the turbidity was once again observed over the following time period, suggesting MT repolymerization as a result of dephosphorylation of the PSer297 Dcx site. We performed two controls for this experiment. In the first, we concurrently added roscovitine together with Cdk5/p25 to the reaction at the beginning of the second incubation to block the kinase activity of Cdk5. This resulted in little change in the overall turbidity of the reaction ( Figure 7B ). We then added tautomycin concurrently with the Spn-PP1 at the beginning of the third incubation to block the phosphatase activity of PP1. Likewise, this resulted in little change in turbidity. Roscovitine or tautomycin alone resulted in little change in turbidity ( Figure 7C ). Turbidity is affected by both MT polymerization and by bundling/cross linking, and thus it was not possible to determine whether these Dcx regulators were altering the organization of MT or leading to depolymerization. To address this, we also performed cosedimentation experiments, to determine the weight of the resultant MT pellet at the end of these experiments. We found that the pellet weight (which correlates to the mass of MTs) showed changes that mirrored turbidity ( Figure 7D ). The data suggests that dynamic phosphorylation and dephosphorylation can influence the effect of Dcx on MT polymerization. A) Purified Dcx and tubulin shows robust increase in turbidity after 1000 s. Subsequently, addition of activated Cdk5/p25 to phosphorylate Ser297 resulted in a net decrease in turbidity over the next 2500 s. Subsequently, addition of roscovitine (to block Cdk5 activity) and Spn-PP1 (to dephosphorylate PSer297 Dcx) resulted in net increase in turbidity over the next 2500 s. (B) Cdk5/p25 that was pretreated with roscovitine, or Spn-PP1 that was pretreated with tautomycin had no net effect on turbidity. (C) Neither roscovitine nor tautomycin alone had any net effect on turbidity. Error bars = SEM from three trials. (D) Cosedimentation analysis. The dephosphorylation of previously phosphorylated Dcx sites was associated with a reinstatement of Dcx MT polymerizing activity, and associated with an increased MT pellet weight. Averaged from two experiments. (E) Model for the role of Dcx and Spn in MT organization during neurite extension. Spn is restricted to the wrist region, where it is complexed with PP1. Spn mediates PP1 dephosphorylation of MT-bound PSer 297 Dcx. This leads to reactivation of Dcx, with subsequent MT crosslinking activity that is necessary for MT bundling in the neurite shaft.
DISCUSSION
Here, we present molecular and genetic data that supports a model of MT bundling at the wrist region during neurite extension. In this model, actin-associated Spn at the neurite wrist enhances the PP1-mediated dephosphorylation of Dcx, which reinstates Dcx's microtubule associated activities, allowing the orderly bundling of MTs into the neurite shaft ( Figure 7E ). This model is supported by data indicating disordered MT bundling along the neurite shaft in Spn À/À and Dcx À/y cultured neurons. In addition, similar MT disorganization was observed along neurite processes in PP1 siRNA treated cortical neurons. A requirement for Spn in mediating Dcx dephosphorylation at S297 was evident in the increased levels of PSer297 Dcx in the Spn À/À brain. MT bundling required the interaction of the Spn/ PP1/Dcx complex, as Spn and Dcx expression were capable of rescuing this splayed MT phenotype in respective knockouts, but expression of mutants lacking the ability to form this complex showed failure to rescue the phenotype. This data suggests that Spn is an important adaptor molecule that spatially restricts PP1-mediated Dcx dephosphorylation during neurite outgrowth.
Genetic Requirements for Corpus Callosal Development
We show delayed axon outgrowth in Dcx À/y brains, yet these fibers eventually project to their correct location in a fashion indistinguishable from WT, suggesting a timedependent defect in axon outgrowth. This delay may enhance the susceptibility of Dcx À/y neurons to further genetic perturbations, such as we observed in the DKO, and has been previously demonstrated for dosage-dependent interaction with Dclk1 (Koizumi et al., 2006b ) and a strain dependent effect of Dcx on CC development (Kappeler et al., 2007) . Spn has been shown to interact with both Dcx and Dclk1 (Tsukada et al., 2003) , therefore it is possible that the ACC observed in the DKO is due to absence of both the Dclk1 or Dcx interaction with Spn. However, since Spn À/À alone does not display ACC, it is likely that Dcx has Spn-independent effects on CC development, so that these axons are delayed but reach the midline within the permissive window for decussation (Wahlsten et al., 2006) . The combined factors may play a role in the variable expressivity of the ACC phenotype in humans with Dcx mutations (Kappeler et al., 2007) .
The Role of Dcx and Spn in Regulation of Neurite Branching
Previous data has suggested a requirement for Dcx in repressing the branching of neurites during migration in both subventricular zone and medial ganglionic eminence neurons (Kappeler et al., 2006; Koizumi et al., 2006a) . This excessive branching was reminiscent of what we observed in cultured primary Dcx À/À or Spn À/À neurons. Branching is typically initiated at the growth cone and along the shaft when MT splay apart, allowing shorter MT to invade the nascent actin-rich branches (Kalil et al., 2000; Szebenyi et al., 1998) . It is likely that failure to maintain a bundled MT cytoskeleton in the neurite shaft underlies the excessive branching that we and others have observed.
Integrators of the Actin and MT Cytoskeleton
Much of the understanding of neurite outgrowth has focused on the role of the actin or MT cytoskeleton independently, and only recently has data emerged to suggest how these two major cytoskeletal components may be coordinated in this process (Dehmelt and Halpain, 2004 ). This integration is presumably mediated by either single molecules that contain both an actin-and MT-binding domain, or by pairs or complexes of molecules that together contain these domains. Several cellular factors such as Pod-1 contain modular actin and MT binding domains and are themselves capable of crosslinking or integrating the two cytoskeletons (Rothenberg et al., 2003) . However, there are few examples of molecular complexes that can bridge between these cytoskeletal components. One such example is the IQGAP1/CLIP-170 interaction, in which activated Rac/CDC42 recruits IQGAP1, an actin binding protein, with CLIP-170, a MT plus-end binding protein, to form a tripartite complex for cellular polarization (Fukata et al., 2002) . The current data suggest that the Spn-Dcx interaction may also mediate crosstalk between the actin and MT cytoskeletons. Spn and Dcx display maximal overlap in distribution in the proximal part of the growing neurite tip, at the site of constriction of the neurite that follows the broad growth cone. Dcx has a well-characterized role in MT modulation (Taylor et al., 2000) and Spn not only targets PP1 but is also capable of crosslinking F-actin into bundles (Satoh et al., 1998) . In vitro studies have shown Dcx can bridge the actin and MT cytoskeletons independent of Spn (Tsukada et al., 2005) . We have also observed that high concentrations of purified Dcx can stabilize and bundle phalloidin labeled actin filaments, however low concentrations of Dcx do not exhibit this effect, but can still crosslink the actin and MT cytoskeletons in combination with Spn. It remains a possibility that Dcx may have Spn-independent interactions with actin in vivo.
Genetic Evidence of MAP Reactivation through Dephosphorylation
Axonal extension appears to consist of three basic events occurring at the growth cone: protrusion, engorgement, and consolidation (Dent and Gertler, 2003) . In this model, protrusion consists of extension of actin-based lamellipodia and filopodia, which then serve as substrates for the extension of MTs. Engorgement consists of movement of vesicles and organelles, likely directed by MT-based transport. Consolidation occurs as the proximal part of the growth cone assumes a cylindrical shape, which probably relies on the bundling of loosely associated MTs. However, little data has been provided to highlight the molecular mechanisms underlying the process. The data presented here suggests that the Dcx/Spn/PP1 interaction may play a role in MT bundling during the consolidation step. We hypothesize that this effect is part of the molecular machinery involved in the transition from splayed to bundled MTs. This is the first genetic demonstration to our knowledge of specific adaptor molecules that are required for MAP reactivation. This may be a general mechanism of reactivation of MAPs. Both genetic and pharmacologic evidence support a role for Spn in the PP1-mediated dephosphorylation of Dcx. Spn is capable of enhancing the PP1-mediated dephosphorylation of the PSer297 site of Dcx. Spn À/À mice had dramatically increased levels of PSer297 Dcx in developing brain. The phosphatases mediating dephosphorylation of Dcx at other sites are not specifically known, although evidence suggests that PP2A may serve to regulate the phosphorylation state of Ser47 (Schaar et al., 2004) . Further identification of the specific phosphatases and targeting subunits for Dcx and other MAPs will require both biochemical and genetic evidence.
EXPERIMENTAL PROCEDURES
Kinase/Phosphatase Assay Proteins were concentrated to 2 mg/ml and used as described (Niethammer et al., 2000; Taylor et al., 2000) . Spn, PP1 (Upstate), and Dcx kinase reaction were incubated for 45 min at 37 C in PP1 buffer.
Animals
Spn animals were maintained in a mixed SvJ/129 background. Dcx animals were maintained on a mixed 129/BlSwiss background. Animal work was performed on littermates, and was carried out in compliance with Institutional Animal Care and Use Committee approved protocols. Approximately 0.2 ml of DiI (10% in DMF) was injected into the medial subcortical region, and processed for visualization after 2 weeks.
Cortical Cultures
Cortical neurons were isolated and cultured as described (Zaman et al., 1999) . Tautomycin and Roscovitine (Calbiochem) were applied for 2 hr.
Electroporation
Isolated cortical neurons from littermates were electroporated with a Nucleofector kit performed according to Mouse Neuron protocol (Amaxa Inc.) with full-length pcDNA3 encoding Spn-GFP or SpnDCC (DL649-Q696), or pcDNA3.1 encoding Dcx-RFP with specific mutations (Tanaka et al., 2004b) . E13.5 intraventricular injection of PP1g siRNA (20uM, SCBT) with 1 mg/ml pGE2hrGFP (electroporation marker) or other tagged constructs, with 0.01% Fast Green (USB, injection marker) was performed as described (Tabata and Nakajima, 2001 ) using 7 mm tweezertrods (Harvard Apparatus). Cortical cultures were generated 48hr post electroporation.
Microscopy
Fluorescent microscopy was performed essentially as described (Tanaka et al., 2004a) . We used rabbit anti-Spn (1:200, Upstate), mouse anti-PP1 (1:50, SCBT), rabbit anti-Dcx (1:200, SCBT), rabbit anti-PSer297 Dcx (1:50), rat anti-L1 (1:200, Chemicon). A branched process was defined as longer than the diameter of the cell body and was more than one cell-body distance from the tip of the main process (to differentiate these from branched growth cone). Electron microscopy was performed using a standard protocol (Yu and Baas, 1994) , sectioned at 80 nM, stained with Sato's lead solution, and captured on a JEM-4000EX IV system. Inter MT distances were measured every 250 nm along the visible process length, with contingency table analysis used for statistics.
Actin/MT Crosslinking Assay Crosslinking was performed as described (Rothenberg et al., 2003) . Lyophylized actin was resuspended in 103 KMEI buffer to 0.4 mg/ml, and stabilized with 60 nM Alexa 488-phalloidin. Rhodaminetubulin:PCP tubulin (1:10) was diluted to 1 mg/ml in BRB80 with 0.5 mM taxol. Crosslinking was tested by combining actin and MT in combinations of 0.75 mg/ml BSA, recombinant Dcx or Spn for 10 min, fixing in 0.1% glutaraldehyde/20% glycerol prior to imaging.
MT Turbidity and Cosedimentation Assay
MT polymerization assays were performed as previously described (Gleeson et al., 1999; Taylor et al., 2000) . After 10 min 3 mg of recombinant Cdk5/p25 and 50 mM ATP were added to the Dcx reaction and diffraction was zeroed. The reaction was allowed to proceed for 43 min at which time 100 mM roscovitine, recombinant Spn (0.1 mg) and 0.001 units of PP1 were added. Diffraction was zeroed and the turbidity was recorded for an additional 35 min. Tautomycin was used at 10 nM. PCP-purified tubulin (100 mg) was incubated with recombinant Dcx (10 mg) that was pretreated with 5 mg active or inactive (100 mM roscovitine) Cdk5/p25 (30 min at 37 C) followed by 0.1 mg/0.001units active or inactive (10 nM tautomycin) Spn/PP1 (20 min 37 C). The100 ml reaction containing 13 G-PEM (80 mM Na Pipes, 0.5 mM MgCl 2 , 1.0 mM EGTA, 1 mM GTP [pH 6.8]) and kinase buffer were pelleted at 37,000 rpm for 20 min at 37 C. The pellets were dried at room temperature for 5 min before weighting.
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